Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
European Journal of Clinical Microbiology & Infectious Diseases
Metadata
Title
Clinical Manifestations and Molecular Epidemiology of Late Recurrent Candidemia, and Implications for Management
Authors
C. J. Clancy
F. Barchiesi
L. Falconi DiFrancesco
A. J. Morris
D. R. Snydman
V. L. Yu
G. Scalise
M. H. Nguyen
Publication date
01-09-2000
Publisher
Springer-Verlag
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 8/2000
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s100960000335

Other articles of this Issue 8/2000

European Journal of Clinical Microbiology & Infectious Diseases 8/2000 Go to the issue

Note

Detection of Isospora belli by Polymerase Chain Reaction Using Primers Based on Small-Subunit Ribosomal RNA Sequences

Article

Nosocomial Candidemia in Non-Neutropenic Patients at an Italian Tertiary Care Hospital

Article

In Vitro Zones of Inhibition of Coated Vascular Catheters Predict Efficacy in Preventing Catheter Infection with Staphylococcus aureus In Vivo

Brief Reports

Molecular Analyses of Possible Mechanisms Coding for Low-Level Mupirocin Resistance in Clinical Staphylococcus aureus Isolates

Review

Management of Cytomegalovirus Retinitis in AIDS

Article

Evaluation of the Vitek 2 System for Susceptibility Testing of Streptococcus pneumoniae Isolates
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits